|
1
|
Gelissen JH, Adjei NN, McNamara B, Mutlu
L, Harold JA, Clark M, Altwerger G, Dottino PR, Huang GS, Santin
AD, et al: Hyperthermic Intraperitoneal chemotherapy in ovarian
cancer. Ann Surg Oncol. 30:5597–5609. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Foster JM, Zhang C, Rehman S, Sharma P and
Alexander HR: The contemporary management of peritoneal metastasis:
A journey from the cold past of treatment futility to a warm
present and a bright future. CA Cancer J Clin. 73:49–71.
2023.PubMed/NCBI
|
|
3
|
Falla-Zuniga LF, Sardi A, King MC,
Lopez-Ramirez F, Kovalik V, Iugai S, Diaz-Montes T and Gushchin V:
Small bowel obstruction and ovarian cancer: Insights from a
propensity-score matched study in patients with and without
hyperthermic intraperitoneal chemotherapy after cytoreductive
surgery. World J Surg Oncol. 23:3182025. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Antonio CCP, Alida GG, Elena GG, Rocío GS,
Jerónimo MG, Luis ARJ, Aníbal ND, Francisco BV, Jesús GRÁ, Pablo RR
and José GM: Cytoreductive surgery with or without HIPEC after
neoadjuvant chemotherapy in ovarian cancer: A phase 3 clinical
trial. Ann Surg Oncol. 29:2617–2625. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ray MD, Kapoor R, Solomi C, Goel D and
Bansal B: The role of complete cytoreductive surgery with
hyperthermic intraperitoneal chemotherapy in ovarian carcinoma:
Where do we stand today? A comprehensive review and clinical
insights from a leading oncology center in India. World J Surg
Oncol. 23:2322025. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Margioula-Siarkou C, Petousis S,
Papanikolaou A, Gullo G, Margioula-Siarkou G, Laganà AS, Dinas K
and Guyon F: Neoadjuvant chemotherapy in advanced-stage ovarian
cancer-state of the art. Prz Menopauzalny. 21:272–275.
2022.PubMed/NCBI
|
|
7
|
Yang LL, Bian YY, Qian HH, Zhu JG, Xu S,
Chen H, Wang S, Li WL and Zeng L: A multicenter, randomized,
double-blind clinical study of Huoxue Tongfu Formula in
postoperative peritoneal adhesions. Journal of Nanjing University
of Traditional Chinese Medicine. 35:130–134. 2019.(In Chinese).
|
|
8
|
Van den Beukel BAW, Toneman MK, van Veelen
F, van Oud-Alblas MB, van Dongen K, Stommel MWJ, van Goor H and Ten
Broek RPG: Elective adhesiolysis for chronic abdominal pain reduces
long-term risk of adhesive small bowel obstruction. World J Emerg
Surg. 18:82023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Erdi M, Saruwatari MS, Rozyyev S, Acha C,
Ayyub OB, Sandler AD and Kofinas P: Controlled release of a
therapeutic peptide in sprayable surgical sealant for prevention of
postoperative abdominal adhesions. ACS Appl Mater Interfaces.
15:14089–14098. 2023.PubMed/NCBI
|
|
10
|
Wu X, Wang Z, Xu J, Yu L, Qin M, Li J, Liu
S, Zheng W, Li Z, Ouyang J, et al: Photocurable injectable Janus
hydrogel with minimally invasive delivery for all-in-one treatment
of gastric perforations and postoperative adhesions. Theranostics.
13:5365–5385. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferns GA, Hassanian SM and Arjmand MH:
Hyperglycaemia and the risk of post-surgical adhesion. Arch Physiol
Biochem. 128:1467–1473. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Imaralu JO, Ani FI, Ayegbusi EO, Oguntade
FA, Nwankpa CC and Olaleye BD: Peritoneal adhesion findings during
laparoscopy: Determinants of occurrence and effect of severity on
operative outcomes in a Nigerian Hospital. Ann Afr Med. 22:145–152.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
American Society of Anesthesiologists, .
ASA Physical Status Classification System. Updated. October 15–2014
Amended. December 13–2020.Available at. Asa physical status
classification system.pdf. May 18–2026
|
|
14
|
Kang SI, Shin HH, Hyun DH, Yoon G, Park JS
and Ryu JH: Double-layer adhesives for preventing anastomotic
leakage and reducing post-surgical adhesion. Mater Today Bio.
23:1008062023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Esber S, Etrusco A, Laganà AS, Chiantera
V, Arsalan HM, Khazzaka A, Dellino M and Sleiman Z: Clinical
outcomes after the use of antiadhesive agents in laparoscopic
reproductive surgery. Gynecol Obstet Invest. 88:325–335. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bezzerri V, Putignani L, Mantuano E,
Polini A, Navarini L, Vomero M, Corberi E, Miacci V, Papuc PE,
Schiavone V and Costa G: A focus on inflammatory and bacterial
biomarkers in secondary peritonitis. Cells. 14:16532025. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng J, Yao S, Shen W, Sun Z, Zhao H, Fu
Y, Gao K and Du N: Clinical study of intraperitoneal infusion of
bevacizumab combined with albumin paclitaxel and carboplatin in
carcinomatous peritoneal adhesion from ovarian cancer. Journal of
International Oncology. 48:660–665. 2021.(In Chinese).
|
|
18
|
Yang ZJ and Shu XY: Effect of minimally
invasive interventional mediation combined with recombinant tissue
plasminogen activator in the treatment of patients with massive
pulmonary embolism. J Pract Med. 42:639–645. 2026.
|
|
19
|
Sun KK and Wu YY: Current status of
internal hernia after gastrectomy for gastric cancer. Langenbecks
Arch Surg. 407:99–104. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lim MC, Chang SJ, Park B, Yoo HJ, Yoo CW,
Nam BH and Park SY; HIPEC for Ovarian Cancer Collaborators, :
Survival after hyperthermic intraperitoneal chemotherapy and
primary or interval cytoreductive surgery in ovarian cancer: A
randomized clinical trial. JAMA Surg. 157:374–383. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Y, Guo J, Li S, Ye L, Lu B, Liu J, Luo
J, Zhu Y, Chen L, Peng T, et al: A Bio-Adaptive Janus-Adhesive
dressing with dynamic lubrication overlayer for prevention of
postoperative infection and adhesion. Adv Sci (Weinh).
12:e25001382025. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao H, Shi ZH, Liu XP, et al: Relationship
between expression of PAI-1 and TGF-β1 of women and their
intrauterine adhesions occurrence after endome-trial polypectomy.
Chinese Journal of Family Planning. 29:156–159. 2021.(In
Chinese).
|
|
23
|
Wang Q, Liu H, Shen Y, Shen L, Li J and
Feng W: The impact of Paclitaxel-based hyperthermic intraperitoneal
chemotherapy in advanced high-grade serous ovarian cancer
patients-interim analysis of safety and immediate efficacy of a
randomized control trial (C-HOC trial). J Ovarian Res. 17:1452024.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Palhares HMDC, da Silva AP, Tomé JM, da
Silva MV, Rodrigues Júnior V, Ribeiro FA, Oliveira MM, Fonseca ECR,
Valle IA and Borges MF: Alterations in the inflammatory markers of
the Tumor Necrosis Factor system in overweight and obese children
and adolescents. PLoS One. 20:e03198322025. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Almaeen AH, Saad-Eldien HM and Gabr H:
INF-γ/TGF-β1-primed umbilical cord mesenchymal stem cells boost the
T-lymphocytes activity: Modulation of CD25 expression and IL-6
secretion. Int J Immunopathol Pharmacol. 39:39463202513150072025.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mekkawy AH, Breakeit M, Rahman MK, Pillai
K, Solanki A, Octavia F, Badar S, Akhter J, Valle SJ and Morris DL:
Safety of BromAc® with Mitomycin C during hyperthermic
intraperitoneal chemotherapy (HIPEC): A preclinical study. Am J
Cancer Res. 15:1213–1223. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steinert F, Hölzen J, Juratli M, Merten J,
Witteler R, Wardelmann E, Pascher A and Eichelmann AK: Ruptured
mature cystic teratoma with granulomatous inflammation masquerading
as pseudomyxoma peritonei. Int Cancer Conf J. 15:74–79. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aronson SL, Lopez-Yurda M, Koole SN,
Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT,
van Gent MDJM, Arts HJG, van Ham MAPC, et al: Cytoreductive surgery
with or without hyperthermic intraperitoneal chemotherapy in
patients with advanced ovarian cancer (OVHIPEC-1): Final survival
analysis of a randomised, controlled, phase 3 trial. Lancet Oncol.
24:1109–1118. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin Y, Shen C, Guo XK, Li Y, Wang DD, Chen
X, Wang Z, Wu K, Tao KX and Wu CQ: Safety evaluation of
hyperthermic intraperitoneal chemotherapy in preventing peritoneal
metastasis after radical resection for locally advanced gastric
cancer. Chin J Gastrointest Surg. 25:48–55. 2022.(In Chinese).
|
|
30
|
Ghasemi SH, Ahmadian MT, Assempour A and
Ahmadi Tafti SH: Comparative study on efficacy of thrombolytic
protocols: Dual therapy against standard tPA regimen. Biophys J.
124:1704–1714. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tucker TA, Komissarov AA and Idell S:
Perspective and update: Intrapleural fibrinolytic therapy for
pleural infections and other forms of pleural organization. Respir
Res. 26:1052025. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma C, Gao L, Hong Z, Xu J and Chen L:
Identification and analysis of risk factors for poor prognosis in
patients with acute ischemic stroke undergoing thrombolytic
therapy. Medicine (Baltimore). 104:e465752025. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei X, Liao P, Chen X and Wu W: Risk
factors affecting prognosis in pseudomyxoma peritonei patients
after hyperthermic intraperitoneal chemotherapy and cytoreductive
surgery: A systematic review and meta-analysis. Int J Surg.
111:9622–9633. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang L, Chen J, Yan Z, Chen Z, Yue Z and
Sun H: Effects of inflammation and immunoregulatory responses in
the formation of peritoneal adhesion. International Journal of
Biomedical Engineering. 44:401–405. 4172021.(In Chinese).
|
|
35
|
Cao J: Protective effect and mechanism of
dehydroepiandrosterone on mice with ulcerative colitis. Jiangsu;
Nanjing Agricultural University: 2022
|
|
36
|
Xiao L, Du M, Yan M, Zhang F and Ning C:
Ultrasonic presentation of cryptogenic multifocal ulcerative
stenosing enteritis: a case report. Chinese Journal of
Ultrasonography. 32:1094–1096. 2023.(In Chinese).
|
